Unlocking the potential of
genomic medicine


Firm Analyst
Matthew Andrews
JMP Securities
Jason Butler
Needham & Co.
Chad Messer

Aevi Genomic Medicine is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Aevi Genomic Medicine's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Aevi Genomic Medicine or its management. Aevi Genomic Medicine does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.